Alfred Scheidegger

Alfred Scheidegger was the founder of Nextech Invest AG, founded in 1998, and served as Member of the Board of Directors from 2023 to 2025.
Current jobs include Deputy Chairman at Dottikon ES Holding AG since 2020, Chairman at The Genetics Co., Inc. since 2009, Chairman at Nextech Holding AG, Chairman at Wemedoo AG since 2023, Non-Executive Director at Dottikon Exclusive Synthesis AG, Director at Nextech III GP AG, Non-Executive Director at Dottikon Es Management AG, Director at Nextech Venture Principals Ltd., and Director at 8stogg AG since 2020.
Former jobs include Chief Executive Officer at Swiss Scientific Computing Center from 1992 to 1995, Director at TRACON Pharmaceuticals, Inc. from 2012 to 2014, Director-Supervisory Board at Ganymed Pharmaceuticals AG, Director & Administrative Director at Swiss Federal Institute of Technology from 1995 to 1998, Director at ImVisioN Therapeutics AG, Director at Palyon Medical Corp., Director at Cleave Therapeutics, Inc. from 2016 to 2019, and Member-Foundation Board at Rising Tide Foundation from 2017 to 2021.
Education includes a doctorate from the University of Basel and graduate studies at Kyoto University.